We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+18.49%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$1.78B
AUM Growth
+$242M
Cap. Flow
-$5.15M
Cap. Flow %
-0.29%
Top 10 Hldgs %
52.41%
Holding
310
New
14
Increased
56
Reduced
56
Closed
5

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$44.9M
2
WST icon
West Pharmaceutical
WST
+$3.89M
3
ROK icon
Rockwell Automation
ROK
+$3.51M
4
ADBE icon
Adobe
ADBE
+$3.37M
5
AAPL icon
Apple
AAPL
+$2.92M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$37M
2
NVDA icon
NVIDIA
NVDA
+$9M
3
AMZN icon
Amazon
AMZN
+$6.64M
4
EPAM icon
EPAM Systems
EPAM
+$6.47M
5
PSA icon
Public Storage
PSA
+$5.33M

Sector Composition

Rank Sector Weight
1 Technology 43.49%
2 Healthcare 15.9%
3 Consumer Discretionary 13.64%
4 Communication Services 9.44%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLD icon
101
Prologis
PLD
$136B
$2.46M 0.14%
20,067
-8
-0% -$984
ENPH icon
102
Enphase Energy
ENPH
$4.63B
$2.43M 0.14%
14,525
-3,432
-19% -$613K
FIVE icon
103
Five Below
FIVE
$11.6B
$2.36M 0.13%
12,011
-9,676
-45% -$1.89M
INSP icon
104
Inspire Medical Systems
INSP
$1.47B
$2.27M 0.13%
7,000
– –
CVS icon
105
CVS Health
CVS
$135B
$2.24M 0.13%
32,400
-13
-0% -$925
LPLA icon
106
LPL Financial
LPLA
$27B
$2.22M 0.13%
10,224
– –
DE icon
107
Deere & Co
DE
$165B
$2.14M 0.12%
5,275
+311
+6% +$119K
VEEV icon
108
Veeva Systems
VEEV
$33.8B
$2.05M 0.12%
+10,373
New +$1.89M
HCA icon
109
HCA Healthcare
HCA
$88.4B
$1.98M 0.11%
6,537
-2
-0% -$556
MCK icon
110
McKesson
MCK
$104B
$1.97M 0.11%
4,607
+1,189
+35% +$457K
ABT icon
111
Abbott
ABT
$187B
$1.96M 0.11%
17,989
+10,736
+148% +$1.14M
SYK icon
112
Stryker
SYK
$135B
$1.9M 0.11%
+6,206
New +$1.79M
BDC icon
113
Belden
BDC
$3.97B
$1.88M 0.11%
19,607
– –
BSY icon
114
Bentley Systems
BSY
$11.2B
$1.85M 0.1%
+34,084
New +$1.59M
SRPT icon
115
Sarepta Therapeutics
SRPT
$1.64B
$1.81M 0.1%
15,838
-8,096
-34% -$1.04M
ZBH icon
116
Zimmer Biomet
ZBH
$18.8B
$1.81M 0.1%
+12,378
New +$1.68M
DV icon
117
DoubleVerify
DV
$1.77B
$1.79M 0.1%
+46,068
New +$1.49M
CME icon
118
CME Group
CME
$95.4B
$1.79M 0.1%
9,645
-4
-0% -$739
NBIX icon
119
Neurocrine Biosciences
NBIX
$18.2B
$1.73M 0.1%
18,294
– –
IBM icon
120
IBM
IBM
$213B
$1.68M 0.09%
12,569
-6
-0% -$774
NOC icon
121
Northrop Grumman
NOC
$76B
$1.63M 0.09%
3,573
-2
-0.1% -$907
WFC icon
122
Wells Fargo
WFC
$254B
$1.62M 0.09%
37,903
-11,610
-23% -$467K
PPG icon
123
PPG Industries
PPG
$24.9B
$1.61M 0.09%
10,835
-4
-0% -$558
EXAS
124
DELISTED
Exact Sciences
EXAS
$1.6M 0.09%
17,083
+1,123
+7% +$87.6K
GE icon
125
GE Aerospace
GE
$364B
$1.59M 0.09%
18,167
+1,077
+6% +$87.2K
3 4
5
6 7

Similar funds

ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
AG
Ascent Group Virginia Beach, Virginia $2.89B AUM 19.6% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
CWM
Calamos Wealth Management Naperville, Illinois $2.91B AUM 25.59% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return

Silvant Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Silvant Capital Management held 310 positions worth $1.78B, up 16% from $1.54B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Silvant Capital Management's Q2 2023 filing shows 14 new, 56 increased, 56 reduced and 5 closed positions. Its largest new stake was West Pharmaceutical: 10,893 shares worth $4.17M. The largest sale was Estee Lauder, an estimated $37M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Silvant Capital Management's largest Q2 2023 buy was West Pharmaceutical: 10,893 shares worth $4.17M.
  • Silvant Capital Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $44.9M increase.
  • Silvant Capital Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $9M.
  • Silvant Capital Management fully exited Estee Lauder in Q2 2023, selling an estimated $37M.
  • Silvant Capital Management's ten largest holdings make up 52% of its $1.78B portfolio in Q2 2023.
  • Silvant Capital Management opened 14 new positions and closed 5 in Q2 2023.
  • Silvant Capital Management's portfolio value rose 16% quarter-over-quarter to $1.78B.

Based on Silvant Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.